None
EN
Prime Medicine (NASDAQ:PRME) Announces Earnings Results, Meets Estimates
['Trevor Kearing']
Daily Political
Prime Medicine (NASDAQ:PRME – Get Free Report) posted its earnings results on Thursday.
Prime Medicine had a negative return on equity of 188.82% and a negative net margin of 4,917.55%.
Prime Medicine Price PerformanceNASDAQ:PRME traded down $0.13 during trading hours on Thursday, hitting $2.95.
The company’s 50 day moving average price is $3.28 and its 200-day moving average price is $3.49.
Recommended StoriesReceive News & Ratings for Prime Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prime Medicine and related companies with MarketBeat.com's FREE daily email newsletter.